当前位置:首页 - 行情中心 - 蔚蓝生物(603739) - 财务分析 - 现金流量表

蔚蓝生物

(603739)

  

流通市值:39.47亿  总市值:39.47亿
流通股本:2.53亿   总股本:2.53亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金376,443,662.81,291,840,327.68978,817,270.22654,125,190.83
  收到的税费返还1,665,440.612,496,019.322,628,708.253,746,743.82
  收到其他与经营活动有关的现金6,416,605.2676,331,639.0940,981,913.7930,024,355.18
  经营活动现金流入小计384,525,708.671,370,667,986.091,022,427,892.26687,896,289.83
  购买商品、接受劳务支付的现金206,020,731.88626,485,350.58510,577,249.16346,572,093.03
  支付给职工以及为职工支付的现金77,034,647.91228,550,244.45176,962,134.76125,985,893.14
  支付的各项税费26,296,269.3386,334,252.5269,735,476.7847,898,194.26
  支付其他与经营活动有关的现金67,556,952.79233,890,566.77201,951,216.94115,238,187.96
  经营活动现金流出小计376,908,601.911,175,260,414.32959,226,077.64635,694,368.39
  经营活动产生的现金流量净额7,617,106.76195,407,571.7763,201,814.6252,201,921.44
二、投资活动产生的现金流量:
  取得投资收益收到的现金-16,360,106.4415,236,443.237,595,907.63
  处置固定资产、无形资产和其他长期资产收回的现金净额2,7142,077,529.8620,824.24-
  处置子公司及其他营业单位收到的现金净额-406,794.34--
  收到的其他与投资活动有关的现金242,600,000932,655,482.91631,249,000300,143,584.76
  投资活动现金流入小计242,602,714951,499,913.55646,506,267.47307,739,492.39
  购建固定资产、无形资产和其他长期资产支付的现金41,340,500.86104,719,737.3362,956,067.6256,794,350.75
  投资支付的现金-24,375,00016,875,00016,875,000
  取得子公司及其他营业单位支付的现金-18,360,00018,360,00018,360,000
  支付其他与投资活动有关的现金284,100,495846,503,218.85586,399,000261,287,743.76
  投资活动现金流出小计325,440,995.86993,957,956.18684,590,067.62353,317,094.51
  投资活动产生的现金流量净额-82,838,281.86-42,458,042.63-38,083,800.15-45,577,602.12
三、筹资活动产生的现金流量:
  吸收投资收到的现金780,000---
  其中:子公司吸收少数股东投资收到的现金780,000---
  取得借款收到的现金139,470,088.29842,678,389.09573,362,488.53523,362,488.53
  筹资活动现金流入小计140,250,088.29842,678,389.09573,362,488.53523,362,488.53
  偿还债务支付的现金60,050,000915,246,820.27457,350,000446,919,002.42
  分配股利、利润或偿付利息支付的现金13,567,661.7968,902,487.5557,475,911.651,917,026.37
  其中:子公司支付给少数股东的股利、利润9,300,00013,668,532.7216,357,00016,357,000
  支付其他与筹资活动有关的现金--43,698,482.2-
  筹资活动现金流出小计73,617,661.79984,149,307.82558,524,393.8498,836,028.79
  筹资活动产生的现金流量净额66,632,426.5-141,470,918.7314,838,094.7324,526,459.74
四、汇率变动对现金及现金等价物的影响-126,900.55--
五、现金及现金等价物净增加额-8,588,748.611,605,510.9639,956,109.231,150,779.06
  加:期初现金及现金等价物余额233,326,458.32221,720,947.36221,720,947.36221,720,947.36
  期末现金及现金等价物余额224,737,709.72233,326,458.32261,677,056.56252,871,726.42
补充资料:
  净利润-92,172,274.48-42,310,522.15
  资产减值准备-2,684,134.98-519,852.13
  固定资产和投资性房地产折旧-101,247,766.7-53,752,216.91
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-101,247,766.7-53,752,216.91
  无形资产摊销-9,738,713.12-4,857,036.75
  长期待摊费用摊销-1,207,508.1-625,738.29
  处置固定资产、无形资产和其他长期资产的损失-602,390.96--559,819.91
  固定资产报废损失-475,657.22--
  公允价值变动损失--8,317,637.54--7,949,648.34
  财务费用-21,878,828.93-10,251,476.82
  投资损失-1,239,485.35--
  递延所得税--493,706.13--887,015.7
  其中:递延所得税资产减少-1,071,641.33--723,373.06
    递延所得税负债增加--1,565,347.46--163,642.64
  存货的减少-13,844,769.31--5,092,211.56
  经营性应收项目的减少--40,879,324.66--22,569,488.3
  经营性应付项目的增加--6,460,650.3--21,621,555.03
  现金的期末余额-233,326,458.32-252,871,726.42
  减:现金的期初余额-221,720,947.36-221,720,947.36
  现金及现金等价物的净增加额-11,605,510.96-31,150,779.06
公告日期2025-04-262025-04-262024-10-292024-08-28
审计意见(境内)标准无保留意见
TOP↑